Ignis Therapeutics
PrivateLast Round
Series A
Nov 11, 2021
Total Funding Raised
$185M
Company Overview
Ignis Therapeutics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in November 2021.
Ignis Therapeutics is a biotechnology company that develops and commercializes innovative therapies for central nervous system (CNS) disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ignis Therapeutics Comparables
Compare Ignis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tenacia Biotechnology | 89% | |
| NeuroFront Therapeutics | 79% | |
| NeuroGen Pharma | 77% |
For institutional investors. Book with your work email.
Ignis Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Ignis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KB Investment | Series A |
| HBM Healthcare Investments | Series A |
| 6 Dimensions Capital | Series A |
| Mubadala Investment Company | Series A |
| Goldman Sachs | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2021
$185M round led by 6 Dimensions Capital.
For institutional investors. Book with your work email.
Ignis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ignis Therapeutics's valuation, stock price, and market status.
Is Ignis Therapeutics a public or private company?
Ignis Therapeutics is a private company.
What is the current stock price of Ignis Therapeutics?
Ignis Therapeutics is a private company, so its shares have no public market price. Caplight tracks Ignis Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ignis Therapeutics worth (valuation)?
Valuation information for Ignis Therapeutics is not publicly available.
Can I buy Ignis Therapeutics stock?
Ignis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ignis Therapeutics's last funding round?
Ignis Therapeutics's most recent funding round was Series A on November 11, 2021.
Who are the main investors in Ignis Therapeutics?
Key investors in Ignis Therapeutics include 6 Dimensions Capital.
Will Ignis Therapeutics IPO soon?
No public IPO plans have been announced for Ignis Therapeutics.
How can I track Ignis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Ignis Therapeutics's shares on secondary markets.